The Week in Review: May 18 – May 25, 2018

Friday, May 25, 2018 News Recap: In Brief: Liver Stiffness Measurement as a Potential Screening Tool for Liver-Related Events in HCV. The rate of advanced liver fibrosis in community as opposed to urban settings appears to be significant (16.5%) and often underdiagnosed; therefore, liver stiffness measurement is a feasible community screening tool that can be used to predict liver-related events, according to a study published in the Journal of He...

Study finds three major factors for liver cancer

Fatty liver disease, diabetes and a triglycerides level of above 160 milligrams per deciliter (mg/dl) are three major risk factors for developing liver cancer, and the disease’s progression does not necessarily include chronic hepatitis or cirrhosis, the National Health Research Institutes (NHRI) said yesterday. Liver cancer has been the second-leading cause of cancer deaths for many years, and about 85 percent of cases have been associated with chronic h

The Week in Review: April 20 – April 27, 2018

Friday, April 27, 2018 News Recap: Warnings: Synthetic cannabinoids and Hepatitis A could be a fatal combination. On April 9, 2018, the Missouri Department of Health and Senior Services (DHSS) issued a news release – “Use of Synthetic Cannabinoids Linked to Severe Bleeding in the US,” informing the public about the national outbreak of bleeding illnesses among those consuming synthetic cannabinoids which appear to have been contaminated with a long-...

NCCN: Screen for Liver Cancer in Patients at Risk

In the last 20 years in the United States, the incidence of hepatocellular carcinoma (HCC) has tripled from about 2 to 7 per 100,000 adults. In addition to the rising incidence, the cancer is also one of the most deadly, with a 5-year survival rate of only 18%. These comments were made here by Anne Covey, MD, a radiologist from the Memorial Sloan Kettering Cancer Center, New York City, at the National Comprehensive Cancer Network (NCCN) 23rd Annual Confer